Andrew Whelan, President, CEO and Chairman of BioElectronics, Corp. , developer of ActiPatch, an FDA-cleared, drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers pulsed electromagnetic therapy to relieve pain and speed healing, today issued the following letter to shareholders.
More: continued here